drugset / Trial / NCT06054880
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
RandomizedCrossoverQuadruple-blindDiagnostic
Summary
This is a randomized, multicenter study to evaluate the efficacy and safety of two dose levels (2.5 mL and 5.0 mL) of Bludigo when used as an aid in the determination of ureteral patency.
Timeline
- Start
- 2023-10-12
- Primary completion
- 2026-01-31
- Completion
- 2026-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INDIGOTINDISULFONATE | Small molecule | 2.5 ml | — |
| Subject | INDIGOTINDISULFONATE | Small molecule | 5 ml | — |